{"first_name":"Russell","last_name":"Hirsch","permalink":"russell-hirsch","crunchbase_url":"http://www.crunchbase.com/person/russell-hirsch","homepage_url":null,"birthplace":null,"twitter_username":null,"blog_url":null,"blog_feed_url":null,"affiliation_name":"Unaffiliated","born_year":null,"born_month":null,"born_day":null,"tag_list":null,"alias_list":null,"created_at":"Wed Jun 03 09:48:54 UTC 2009","updated_at":"Wed Jun 03 09:52:11 UTC 2009","overview":"<p>Russell is a Managing Director of Prospect Venture Partners. Russell co-founded Prospect Venture Partners II and III, as dedicated life science funds with over $1 billion in capital under management. Prior to establishing Prospect Venture Partners II and III, Russell was a member of the Health Care Technology Group at Mayfield. He joined Mayfield in 1992, served as a Venture Partner from 1993 to 1994 and as a General Partner from 1995-2000. Russell played a key role in Mayfield&#8217;s investment activities in the biotechnology and medical device sectors. As an Associate, he participated actively in the incubation of Millennium Pharmaceuticals and as a General Partner he was responsible for the incubation of Intuitive Surgical Devices both of which are now publicly traded. (NASDAQ: MLNM), (NASDAQ:ISRG).</p>\n\n<p>Prior to Mayfield, Russell was at the University of California San Francisco from 1984-1992 where he was engaged in biomedical research. His work, published in a variety of respected journals, focused on important aspects of hepatitis B viral replication. His descriptions of the reverse transcription and packaging functions of polymerase gene products merited publication in Nature.</p>\n\n<p>Russell serves or has served on the Board of Directors of Intuitive Surgical (NASDAQ: ISRG), Hansen Medical (NASDAQ: HNSN), Opus Medical (NASDAQ: ARTC), Orquest (NASDAQ: JNJ), AVEO Pharmaceuticals, Visiogen, Baxano, Dfine, Allux Medical, SentreHEART, Portola Pharmaceuticals and several other privately-held companies. Russell serves as the Vice Chairman of the BOD of Interplast and on the Genetics Advisory Council of the Harvard Medical School-Partners Healthcare Center for Genetics and Genomics.</p>","image":{"available_sizes":[[[121,150],"assets/images/resized/0004/6460/46460v1-max-150x150.jpg"],[[151,187],"assets/images/resized/0004/6460/46460v1-max-250x250.jpg"],[[151,187],"assets/images/resized/0004/6460/46460v1-max-450x450.jpg"]],"attribution":""},"degrees":[{"degree_type":"M.D. and Ph.D.","subject":"Biochemistry","institution":"University of California","graduated_year":null,"graduated_month":null,"graduated_day":null}],"relationships":[{"is_past":false,"title":"Managing Director","firm":{"name":"Prospect Venture Partners","permalink":"prospect-venture-partners","type_of_entity":"financial_org","image":{"available_sizes":[[[150,81],"assets/images/resized/0003/4207/34207v1-max-150x150.png"],[[195,106],"assets/images/resized/0003/4207/34207v1-max-250x250.png"],[[195,106],"assets/images/resized/0003/4207/34207v1-max-450x450.png"]],"attribution":null}}}],"investments":[{"funding_round":{"round_code":"seed","source_url":"http://techcrunch.com/2011/11/09/glooko-iphones-diabetes/","source_description":"TechCrunch","raised_amount":1000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":11,"funded_day":1,"company":{"name":"Glooko","permalink":"glooko","image":{"available_sizes":[[[150,64],"assets/images/resized/0016/1693/161693v1-max-150x150.png"],[[192,83],"assets/images/resized/0016/1693/161693v1-max-250x250.png"],[[192,83],"assets/images/resized/0016/1693/161693v1-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"video_embeds":[],"external_links":[],"web_presences":[]}